de Castro-Afonso L H, Nakiri G S, Oliveira R S, Santos M V, Santos A C Dos, Machado H R, Abud D G
Division of Interventional Neuroradiology, Medical School of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900, Monte Alegre, Ribeirão Preto, SP, Brazil, 14048-090.
Division of Pediatric Neurosurgery, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Neuroradiology. 2016 Jun;58(6):585-594. doi: 10.1007/s00234-016-1666-1. Epub 2016 Feb 24.
Intracranial arteriovenous malformations (AVMs) are the most frequent cause of hemorrhagic strokes in the pediatric population. The study aim was to retrospectively assess the safety and efficacy of Onyx embolization with the intention to cure AVMs in a pediatric population.
A retrospective analysis of all patients (<18 years) who underwent endovascular embolization using Onyx at our institution was conducted. The primary endpoint was the composite complete angiographic occlusion of AVM immediately after the last embolization session that had no procedure-related complication requiring emergency surgery. Secondary endpoints were angiographic occlusion rates, procedure-related complications, and clinical outcomes after treatment and at the 6-month follow-up
Twenty-three patients (mean age, 11.7 years) underwent a total of 45 embolization sessions. The median Spetzler-Martin grade was 3 (range 1 to 4). The primary endpoint was achieved in 19 patients (82.6 %). Complete angiographic occlusion of the AVM was obtained in 21 patients (91.3 %) immediately after embolization and at the 6-month follow-up. Embolization-related complications were observed in three patients (13 %). None of the complications resulted in permanent functional disability or death. In two patients (8.7 %), the AVM could not be completely occluded by embolization alone and the patients were referred to radiosurgery and microsurgery, respectively.
Onyx embolization of AVM in pediatric patients with the intention to cure resulted in high occlusion rates without increasing neurological disability or death. The development of new embolization techniques and devices seems to improve the safety of Onyx embolization.
颅内动静脉畸形(AVM)是儿童人群出血性中风最常见的病因。本研究旨在回顾性评估使用Onyx栓塞治疗儿童AVM的安全性和有效性。
对在我院接受Onyx血管内栓塞治疗的所有年龄小于18岁的患者进行回顾性分析。主要终点是最后一次栓塞术后即刻实现的AVM完全血管造影闭塞,且无需要急诊手术的与手术相关并发症。次要终点是血管造影闭塞率、与手术相关的并发症以及治疗后和6个月随访时的临床结果。
23例患者(平均年龄11.7岁)共接受了45次栓塞治疗。Spetzler-Martin分级中位数为3(范围1至4)。19例患者(82.6%)达到主要终点。栓塞术后即刻及6个月随访时,21例患者(91.3%)实现了AVM的完全血管造影闭塞。3例患者(13%)观察到与栓塞相关的并发症。所有并发症均未导致永久性功能残疾或死亡。2例患者(8.7%)仅通过栓塞无法完全闭塞AVM,分别转诊至放射外科和显微外科。
旨在治愈的儿童患者AVM的Onyx栓塞导致高闭塞率,且未增加神经功能残疾或死亡。新栓塞技术和装置的发展似乎提高了Onyx栓塞的安全性。